| Androgen-responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation. | |
| | |
MedLine Citation:
|
PMID: 20088946 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The treatment of advanced prostate cancer (CaP) with androgen deprivation therapy inevitably renders the tumours castration resistant and incurable. Under these conditions, neuroendocrine differentiation (NED) of CaP cells occurs and neuropeptides released by neuroendocrine cells facilitate tumour progression. Pharmacological strategies aiming to prevent or delay NED during androgen ablation could, therefore, increase the effectiveness of the therapy. Mechanisms and pathways inducing NED in CaP are poorly understood and data are often discordant. In the present study, we used several CaP cell lines (androgen-responsive: LNCaP, PC3-AR, 22RV1 and -irresponsive: DU145 and PC3) to evaluate NED after androgen deprivation or treatment with epidermal growth factor (EGF). NED was determined by neuron-specific enolase and chromogranin A expression and by the occurrence of morphological changes in the cells. Androgen-deprivation conditions induced NED in LNCaP and PC3-AR, but not in 22Rv1, PC3 and DU145 cells. LNCaP and PC3-AR cells also became resistant to thapsigargin-induced apoptosis. In all the AR-positive cell lines, androgen deprivation caused a decrease in androgen receptor expression indicating that it is downregulated irrespective of NED induction. Treatment with EGF induced NED in DU145 cells and the EGF receptor inhibitor gefinitib prevented the process. On the contrary, no effect of EGF was demonstrated in LNCaP or 22Rv1 cells. CaP cell lines did not respond univocally to treatments inducing NED, suggesting that studies on this topic should be performed in a wide spectrum of cell models which can be more indicative of the tumour variability in vivo. |
| | |
Authors:
|
S Marchiani; L Tamburrino; G Nesi; M Paglierani; S Gelmini; C Orlando; M Maggi; G Forti; E Baldi |
Related Documents
:
|
20082326 - The cancer-related runx2 protein enhances cell growth and responses to androgen and tgf... 20133806 - Basal epithelial stem cells are efficient targets for prostate cancer initiation. 8337186 - A common set of nuclear matrix proteins in prostate cancer cells. 19577536 - Restoration of cyclin d2 has an inhibitory potential on the proliferation of lncap cells. 17767726 - Fitness variation in response to artificial selection for reduced cell area, cell numbe... 21046426 - Putative mechanisms of antitumor activity of cyano-substituted heteroaryles in hela cells. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: International journal of andrology Volume: 33 ISSN: 1365-2605 ISO Abbreviation: Int. J. Androl. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-09 Completed Date: 2011-02-25 Revised Date: 2013-06-03 |
Medline Journal Info:
|
Nlm Unique ID: 8000141 Medline TA: Int J Androl Country: England |
Other Details:
|
Languages: eng Pagination: 784-93 Citation Subset: IM |
Copyright Information:
|
© 2010 The Authors. International Journal of Andrology © 2010 European Academy of Andrology. |
Affiliation:
|
Department of Clinical Physiopathology: Andrology, University of Florence, Florence, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Androgens
/
pharmacology* Cell Differentiation / drug effects Cell Line, Tumor Epidermal Growth Factor / pharmacology Humans Male Neuroendocrine Cells / cytology Phosphopyruvate Hydratase / metabolism Prostatic Neoplasms / drug therapy Quinazolines / pharmacology Receptor, Epidermal Growth Factor Receptors, Androgen |
| Chemical | |
Reg. No./Substance:
|
0/AR protein, human; 0/Androgens; 0/Quinazolines; 0/Receptors, Androgen; 62229-50-9/Epidermal Growth Factor; EC 2.7.10.1/Receptor, Epidermal Growth Factor; EC 4.2.1.11/Phosphopyruvate Hydratase; S65743JHBS/gefitinib |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent o...
Next Document: Subpatent infection with Nucleoside Transporter 1-deficient Plasmodium blood stage parasites confers...